[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100569869":3},{"organization":4,"armGroups":7,"interventions":24,"overallOfficials":37,"centralContacts":41,"locations":47,"responsibleParty":256,"collaborators":36,"id":258,"slug":259,"hasResults":260,"nctId":261,"briefTitle":262,"officialTitle":263,"acronym":36,"eligibilityCriteria":264,"healthyVolunteers":260,"sex":265,"minAge":266,"maxAge":36,"enrollmentInfo":267,"targetDuration":36,"studyType":270,"phases":271,"briefSummary":273,"conditions":274,"keywords":276,"overallStatus":50,"whyStopped":36,"lastUpdateSubmitDate":283,"lastUpdatePostDateStruct":284,"startDateStruct":287,"completionDateStruct":289,"leadSponsor":291,"locationsCount":292},{"fullName":5,"class":6},"CSL Behring","INDUSTRY",[8,14,18],{"label":9,"type":10,"description":11,"interventionNames":12},"CSL889 Regimen 1","EXPERIMENTAL","Participants in this arm will receive CSL889 as per regimen 1.",[13],"Biological: CSL889",{"label":15,"type":10,"description":16,"interventionNames":17},"CSL889 Regimen 2","Participants in this arm will receive CSL889 as per regimen 2.",[13],{"label":19,"type":20,"description":21,"interventionNames":22},"Placebo","PLACEBO_COMPARATOR","Participants in this arm will receive placebo matching to CSL889 regimen.",[23],"Drug: Placebo",[25,32],{"type":26,"name":27,"description":28,"armGroupLabels":29,"otherNames":30},"BIOLOGICAL","CSL889","CSL889 is a solution for infusion to be administered by the IV route.",[9,15],[31],"Hemopexin, human",{"type":33,"name":19,"description":34,"armGroupLabels":35,"otherNames":36},"DRUG","Volume and regimen matched to CSL889 will be administered.",[19],null,[38],{"name":39,"affiliation":5,"role":40},"Study Director","STUDY_DIRECTOR",[42],{"name":43,"role":44,"phone":45,"phoneExt":36,"email":46},"Trial Registration Coordinator","CONTACT","+1 610-878-4697","clinicaltrials@cslbehring.com",[48,62,75,87,98,108,121,131,139,151,163,173,185,196,206,212,222,234,245],{"facility":49,"status":50,"city":51,"state":52,"zip":53,"country":54,"countryCode":55,"cosmosGeoPoint":56,"geoPoint":61,"contacts":36},"Univ. of California, San Francisco Health Care","RECRUITING","Oakland","California","94609","United States","US",{"type":57,"coordinates":58},"Point",[59,60],-122.2708,37.80437,{"lat":60,"lon":59},{"facility":63,"status":64,"city":65,"state":52,"zip":66,"country":54,"countryCode":55,"cosmosGeoPoint":67,"geoPoint":71,"contacts":72},"University of California Irvine","NOT_YET_RECRUITING","Orange","92868",{"type":57,"coordinates":68},[69,70],-117.85311,33.78779,{"lat":70,"lon":69},[73],{"name":74,"role":44,"phone":36,"phoneExt":36,"email":36},"Use Central Contact",{"facility":76,"status":50,"city":77,"state":78,"zip":79,"country":54,"countryCode":55,"cosmosGeoPoint":80,"geoPoint":84,"contacts":85},"Golisano Children's Hospital","Fort Myers","Florida","33908",{"type":57,"coordinates":81},[82,83],-81.84059,26.62168,{"lat":83,"lon":82},[86],{"name":74,"role":44,"phone":36,"phoneExt":36,"email":36},{"facility":88,"status":50,"city":89,"state":78,"zip":90,"country":54,"countryCode":55,"cosmosGeoPoint":91,"geoPoint":95,"contacts":96},"The Foundation for Sickle Cell Disease","Hollywood","33023-6703",{"type":57,"coordinates":92},[93,94],-80.14949,26.0112,{"lat":94,"lon":93},[97],{"name":74,"role":44,"phone":36,"phoneExt":36,"email":36},{"facility":99,"status":50,"city":100,"state":101,"zip":102,"country":54,"countryCode":55,"cosmosGeoPoint":103,"geoPoint":107,"contacts":36},"University of Louisville Hospital","Louisville","Kentucky","40202",{"type":57,"coordinates":104},[105,106],-85.75941,38.25424,{"lat":106,"lon":105},{"facility":109,"status":50,"city":110,"state":111,"zip":112,"country":54,"countryCode":55,"cosmosGeoPoint":113,"geoPoint":117,"contacts":118},"University of Maryland","Baltimore","Maryland","21201",{"type":57,"coordinates":114},[115,116],-76.61219,39.29038,{"lat":116,"lon":115},[119],{"name":120,"role":44,"phone":36,"phoneExt":36,"email":36},"USE CENTRAL Contact",{"facility":122,"status":50,"city":123,"state":124,"zip":125,"country":54,"countryCode":55,"cosmosGeoPoint":126,"geoPoint":130,"contacts":36},"Detroit Medical Center","Detroit","Michigan","48201",{"type":57,"coordinates":127},[128,129],-83.04575,42.33143,{"lat":129,"lon":128},{"facility":132,"status":50,"city":123,"state":124,"zip":133,"country":54,"countryCode":55,"cosmosGeoPoint":134,"geoPoint":136,"contacts":137},"Henry Ford Health System","48202",{"type":57,"coordinates":135},[128,129],{"lat":129,"lon":128},[138],{"name":74,"role":44,"phone":36,"phoneExt":36,"email":36},{"facility":140,"status":50,"city":141,"state":141,"zip":142,"country":54,"countryCode":55,"cosmosGeoPoint":143,"geoPoint":147,"contacts":148},"Mount Sinai Medical Center","New York","10029",{"type":57,"coordinates":144},[145,146],-74.00597,40.71427,{"lat":146,"lon":145},[149],{"name":150,"role":44,"phone":36,"phoneExt":36,"email":36},"USE CENTRAL CONTACT",{"facility":152,"status":50,"city":153,"state":141,"zip":154,"country":54,"countryCode":55,"cosmosGeoPoint":155,"geoPoint":159,"contacts":160},"Jacobi Medical Center","The Bronx","10461",{"type":57,"coordinates":156},[157,158],-73.86641,40.84985,{"lat":158,"lon":157},[161],{"name":162,"role":44,"phone":36,"phoneExt":36,"email":36},"Central Contact",{"facility":164,"status":50,"city":165,"state":166,"zip":167,"country":54,"countryCode":55,"cosmosGeoPoint":168,"geoPoint":172,"contacts":36},"East Carolina University","Greenville","North Carolina","27834",{"type":57,"coordinates":169},[170,171],-77.36635,35.61266,{"lat":171,"lon":170},{"facility":174,"status":50,"city":175,"state":176,"zip":177,"country":54,"countryCode":55,"cosmosGeoPoint":178,"geoPoint":182,"contacts":183},"University of Cincinnati","Cincinnati","Ohio","45267",{"type":57,"coordinates":179},[180,181],-84.51439,39.12711,{"lat":181,"lon":180},[184],{"name":74,"role":44,"phone":36,"phoneExt":36,"email":36},{"facility":186,"status":50,"city":187,"state":176,"zip":188,"country":54,"countryCode":55,"cosmosGeoPoint":189,"geoPoint":193,"contacts":194},"The Ohio State University","Columbus","43085",{"type":57,"coordinates":190},[191,192],-82.99879,39.96118,{"lat":192,"lon":191},[195],{"name":150,"role":44,"phone":36,"phoneExt":36,"email":36},{"facility":197,"status":50,"city":198,"state":199,"zip":200,"country":54,"countryCode":55,"cosmosGeoPoint":201,"geoPoint":205,"contacts":36},"University of Pittsburgh","Pittsburgh","Pennsylvania","15224",{"type":57,"coordinates":202},[203,204],-79.99589,40.44062,{"lat":204,"lon":203},{"facility":207,"status":50,"city":198,"state":199,"zip":208,"country":54,"countryCode":55,"cosmosGeoPoint":209,"geoPoint":211,"contacts":36},"Hillman Cancer Center","15232",{"type":57,"coordinates":210},[203,204],{"lat":204,"lon":203},{"facility":213,"status":50,"city":214,"state":215,"zip":216,"country":54,"countryCode":55,"cosmosGeoPoint":217,"geoPoint":221,"contacts":36},"Virginia Commonwealth University","Richmond","Virginia","23298",{"type":57,"coordinates":218},[219,220],-77.46026,37.55376,{"lat":220,"lon":219},{"facility":223,"status":64,"city":224,"state":36,"zip":225,"country":226,"countryCode":36,"cosmosGeoPoint":227,"geoPoint":231,"contacts":232},"Hacettepe Universitesi","Ankara","06230","Turkey (Türkiye)",{"type":57,"coordinates":228},[229,230],32.85427,39.91987,{"lat":230,"lon":229},[233],{"name":162,"role":44,"phone":36,"phoneExt":36,"email":36},{"facility":235,"status":64,"city":236,"state":36,"zip":237,"country":226,"countryCode":36,"cosmosGeoPoint":238,"geoPoint":242,"contacts":243},"Istanbul Universitesi","Istanbul","34093",{"type":57,"coordinates":239},[240,241],28.94966,41.01384,{"lat":241,"lon":240},[244],{"name":162,"role":44,"phone":36,"phoneExt":36,"email":36},{"facility":246,"status":64,"city":247,"state":36,"zip":248,"country":226,"countryCode":36,"cosmosGeoPoint":249,"geoPoint":253,"contacts":254},"Özel Acibadem Adana Hastanesi","Seyhan","01130",{"type":57,"coordinates":250},[251,252],35.30592,36.98747,{"lat":252,"lon":251},[255],{"name":162,"role":44,"phone":36,"phoneExt":36,"email":36},{"type":257,"investigatorFullName":36,"investigatorTitle":36,"investigatorAffiliation":36,"oldNameTitle":36,"oldOrganization":36},"SPONSOR","100569869","phase-2-safety-efficacy-and-pharmacokinetics-of-csl889-in-adults-and-adolescents-with-sickle-cell-disease-during-vaso-occlusive-crisis-100569869",false,"NCT06699849","Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis","A Phase 2, Multicenter, Randomized, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis","Inclusion Criteria:\n\n* At the time of informed consent:\n\n  * 18 years of age (adults); or\n  * 12 to less than (\\\u003C) 18 years of age (adolescents, where approved and when enrollment for adolescents has been opened by the sponsor, with the endorsement of the Independent Data Monitoring Committee \\[IDMC\\])\n* Diagnosed with SCD (any genotype).\n* Presented at the study site with a new acute VOC necessitating treatment with parenteral opioids.\n\nExclusion Criteria:\n\n* VOC pain onset greater than (\\>) 72 hours before administration of first parenteral opioid.\n* Must not have a history of \\> 5 VOCs requiring hospital admission in the past 6 months; or signs and \u002F or symptoms of ACS; or new neurological symptoms suggestive of acute stroke or transient ischemic attack; or any stage (acute kidney injury) AKI; or been discharged from inpatient hospital admission for VOC or other vaso-occlusive event within 14 days before the current presentation.\n* Serum hemoglobin \\\u003C 6 g\u002FdL, serum ferritin ≥ 2000 ng\u002FmL, receiving an approved medication for SCD that has not been on a stable, well-tolerated regimen, currently taking methadone or buprenorphine.","ALL","12 Years",{"count":268,"type":269},70,"ESTIMATED","INTERVENTIONAL",[272],"PHASE2","This is a phase 2, randomized, multiple-dose, placebo-controlled study designed to evaluate the safety, efficacy, and pharmacokinetics (PK) of CSL889 (human hemopexin) when given intravenously (IV) to adults and adolescents with sickle cell disease (SCD) experiencing vaso-occlusive crises (VOC). The main objectives of the study are to evaluate the safety and tolerability of CSL889 in study participants, and to assess how CSL889 affects the time it takes for VOC to resolve in participants with SCD.",[275],"Sickle Cell Disease Vaso-occlusive Crisis",[277,278,279,280,281,282],"Sickle cell disease","Acute kidney injury","Pharmacokinetics","Acute chest syndrome","Vaso-occlusive crisis","Hemopexin","2026-05-13",{"date":285,"type":286},"2026-05-14","ACTUAL",{"date":288,"type":286},"2025-08-07",{"date":290,"type":269},"2027-10-22",{"name":5,"class":6},19]